Wednesday, August 08, 2007

Health Canada approves cannabis-derived pain drug for certain cancer patients

From Canada East:
A cannabis-derived drug that's been on the market for two years in Canada to relieve pain in multiple sclerosis patients is now approved for use by certain patients with cancer.

Health Canada has approved Sativex as an added pain relief treatment for adults with advanced cancer who have moderate to severe pain when using the highest tolerated dose of strong opioid therapy, said a statement Tuesday from Bayer Inc.

Patients can self-administer Sativex by spraying it into the mouth - under the tongue or on the inside of the cheek.

Advanced cancers usually cannot be cured, and many of these patients will experience moderate to severe pain, according to various pain studies. ...more

No comments: